These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 24576228)

  • 1. Pregnancy after definitive treatment for Graves' disease--does treatment choice influence outcome?
    Elston MS; Tu'akoi K; Meyer-Rochow GY; Tamatea JA; Conaglen JV
    Aust N Z J Obstet Gynaecol; 2014 Aug; 54(4):317-21. PubMed ID: 24576228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pregnancy and the thyroid gland].
    Lieutaud H
    Ann Med Interne (Paris); 1999 Sep; 150(5):397-407. PubMed ID: 10544750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for neonatal thyroid dysfunction in pregnancies complicated by Graves' disease.
    Uenaka M; Tanimura K; Tairaku S; Morioka I; Ebina Y; Yamada H
    Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():89-93. PubMed ID: 24726178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent high TRAb values during pregnancy predict increased risk of neonatal hyperthyroidism following radioiodine therapy for refractory hyperthyroidism.
    Hamada N; Momotani N; Ishikawa N; Yoshimura Noh J; Okamoto Y; Konishi T; Ito K; Ito K
    Endocr J; 2011; 58(1):55-8. PubMed ID: 20962435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRAb elevations occurred even in the third trimester; a case of a mother of a child with neonatal thyroid dysfunction, who received radioactive iodine therapy for Graves' disease.
    Suzuki N; Yoshihara A; Yoshimura Noh J; Kinoshita K; Ohnishi J; Saito M; Sugino K; Ito K
    Endocr J; 2020 Oct; 67(10):1019-1022. PubMed ID: 32522908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of thyrotropin receptor antibody levels on fetal development in two successive pregnancies in a woman with Graves' disease.
    Bjørgaas MR; Farstad H; Christiansen SC; Blaas HG
    Horm Res Paediatr; 2013; 79(1):39-43. PubMed ID: 23154300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Third-Generation Thyrotropin Receptor Antibody (TRAb) assay for predicting neonatal thyroid dysfunction in pregnant women with Graves' disease.
    Priyanka R; Sridhar S; Sumathi B; Jeyaraj AR; Natarajan V; Subbiah E; Raghavan KS; Sangumani J
    Endocrine; 2024 May; 84(2):500-508. PubMed ID: 37861945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Foetal and neonatal thyroid disorders.
    Radetti G; Zavallone A; Gentili L; Beck-Peccoz P; Bona G
    Minerva Pediatr; 2002 Oct; 54(5):383-400. PubMed ID: 12244277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in the use of definitive treatment options in the management of Graves' disease: a UK clinician survey.
    Hookham J; Collins EE; Allahabadia A; Balasubramanian SP
    Postgrad Med J; 2017 Apr; 93(1098):198-204. PubMed ID: 27531964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy insight: management of Graves' disease during pregnancy.
    Chan GW; Mandel SJ
    Nat Clin Pract Endocrinol Metab; 2007 Jun; 3(6):470-8. PubMed ID: 17515891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study.
    Laurberg P; Wallin G; Tallstedt L; Abraham-Nordling M; Lundell G; Tørring O
    Eur J Endocrinol; 2008 Jan; 158(1):69-75. PubMed ID: 18166819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Radioiodine versus surgery in the treatment of Graves' hyperthyroidism].
    Jukić T; Stanicić J; Petric V; Kusić Z
    Lijec Vjesn; 2010; 132(11-12):355-60. PubMed ID: 21294325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy.
    Laurberg P; Bournaud C; Karmisholt J; Orgiazzi J
    Eur J Endocrinol; 2009 Jan; 160(1):1-8. PubMed ID: 18849306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Basedow's disease].
    Scheidegger K
    Schweiz Rundsch Med Prax; 1993 Aug; 82(32):840-4. PubMed ID: 7690495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Graves' disease during pregnancy in the Poitou-Charentes Region.
    Hawken C; Sarreau M; Bernardin M; Delcourt AC; Muller A; Lefort G; Pernollet P; Marechaud R
    Ann Endocrinol (Paris); 2016 Oct; 77(5):570-577. PubMed ID: 27375108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evolution of diagnostic and therapeutic criteria in Graves' disease in Spain. Comparison of the results of 2 surveys in 1987 and 1995].
    Escobar Jiménez F; Luna López V; Fernández Soto ML; Quezada Charneco M; Glinoer D
    Med Clin (Barc); 1998 Sep; 111(6):205-10. PubMed ID: 9789225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioactive iodine therapy in Graves' hyperthyroidism.
    Sankar R; Sripathy G
    Natl Med J India; 2000; 13(5):246-51. PubMed ID: 11190053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current problems in the treatment of Graves' disease in pregnancy and in lactation].
    Momotani N
    Nihon Rinsho; 2006 Dec; 64(12):2297-302. PubMed ID: 17154095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperthyroidism in pregnancy.
    Mestman JH
    Curr Opin Endocrinol Diabetes Obes; 2012 Oct; 19(5):394-401. PubMed ID: 22922367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism.
    Baskin HJ; Cobin RH; Duick DS; Gharib H; Guttler RB; Kaplan MM; Segal RL;
    Endocr Pract; 2002; 8(6):457-69. PubMed ID: 15260011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.